Pharmaceutical composition comprising factor VII...

Details Pharmaceutical composition comprising factor VII... Pharmaceutical composition comprising factor VII...

2006-07-18

2006-07-18

Kerr, Kathleen M. (Department: 1656)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S350000, C530S300000, C530S384000, C514S001000, C514S002600, C514S012200, C424S094640

Reexamination Certificate

active

07078479

ABSTRACT:
The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide and alpha2-antiplasmin or an alpha2-antiplasmin-related polypeptide, and the use thereof for treating bleeding episodes.

REFERENCES:
patent: 4784950 (1988-11-01), Hagen et al.
patent: 5580560 (1996-12-01), Nicolaisen et al.
patent: 5997864 (1999-12-01), Hart et al.
patent: 0082182 (1987-07-01), None
patent: 0225160 (1991-08-01), None
patent: WO 93/06855 (1993-04-01), None
patent: WO 98/58661 (1998-12-01), None
patent: WO 01/83725 (2001-11-01), None
Radtke et al. Therapeutic potential of alpha2-antiplasmin to improve safety of thrombolytic therapy: In vitro and in vivo studies comparing alpha2-antiplasmin and aprotinin. Blood, (Nov. 15, 1998) vol. 92, No. 10 SUPPL. 1 PART 1-2, pp. 551A.
Lijnen, Abstract, Front Biosci US, vol. 6, pp. D239-D247 (2001).
Hedner, Advances in Experimental Medicine and Biology, vol. 489, pp. 75-88 (2001).
Holmest et al., The Journal of Biological Chemistry, vol. 262, No. 4, pp. 1659-1664 (1987).
Menoud et al., The American Society for Clinical Investigation, vol. 97, No. 11, pp. 2478-2484 (1996).
U.S. Appl. No. 11/069128, a continuation of US 10/200,473 (Publication No. 2003-0040480).
U.S. Appl. No. 2003-0092627 A1 (Application No. 10/271,278).
U.S. Appl. No. 2003-0199444 A1 (Application No. 10/338,471).
U.S. Appl. No. 2003-0118574 A1 (Application No. 10/290,814).
U.S. Appl. No. 2003-0119723 A1 (Application No. 10/287,195).
U.S. Appl. No. 2003-0125256 A1 (Application No. 10/290,591).
U.S. Appl. No. 2003-0118582 A1 (Application No. 10/290,686).
U.S. Appl. No. 2004-0258690 A1 (Application No. 10/891,893).
U.S. Appl. No. 2003-0119743 A1 (Application No. 10/291,266).
U.S. Appl. No. 2003-0073638 A1 (Application No. 10/271,926).
U.S. Appl. No. 11/055,147, a continuation-in-part of U.S. Appl. No. 10/257,121.
(U.S. Appl. No. 2003-0119741) and 10/196,902 (2003-0054018).
U.S. Appl. No. 2004-0006020 A1 (Application No. 10/437,522).
U.S. Appl. No. 2003-0203845 A1 (Application No. 10/292,644).
U.S. Appl. No. 2003-0118580 A1 (Application No. 10/290,684).
U.S. Appl. No. 2003-0054018 (Application No. 10/196,902).
Pharmaceutical Composition Comprising Factor VII Polypeptides and Tissue Plasminogen Inhibitors (Attorney Docket No. 6432.210-US, a continuation of U.S. Appl. No. 10/291,266 ( Patent Publication 2003-0119743 A1)).
Pharmaceutical Compostion Comprising Factor VII Polypeptides and Tranexamic Acid (Attornry Docket No. 6436.214-US, a continuation of U.S. Appl. No. 10/437,674 (Patent Publication No. 2004-0006021 A1)).
U.S. Appl. No. 2003-0119741 A1 (Application No. 10/287,121).
U.S. Appl. No. 2004-0006021 A1 (Application No. 10/437,674).
U.S. Appl. No. 2003-0040480 A1 (Application No. 10/200,473).
U.S. Appl. No. 2003-0124118 A1 (Application No. 10/290,581).

Affiliated with

Also associated with

Rating

Pharmaceutical composition comprising factor VII... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising factor VII..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising factor VII... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3535849